James C. Czirr
2013
In 2013, James C. Czirr earned a total compensation of $437.2K as Executive Chairman and Director at Galectin Therapeutics, a 50% increase compared to previous year.
Compensation breakdown
| Bonus | $120,025 |
|---|---|
| Salary | $240,000 |
| Other | $77,189 |
| Total | $437,214 |
Czirr received $240K in salary, accounting for 55% of the total pay in 2013.
Czirr also received $120K in bonus and $77.2K in other compensation.
Rankings
In 2013, James C. Czirr's compensation ranked 9,786th out of 12,286 executives tracked by ExecPay. In other words, Czirr earned more than 20.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,786 out of 12,286 | 20th |
Division Manufacturing | 3,630 out of 4,612 | 21st |
Major group Chemicals And Allied Products | 1,150 out of 1,462 | 21st |
Industry group Drugs | 897 out of 1,156 | 22nd |
Industry Pharmaceutical Preparations | 701 out of 890 | 21st |
Source: SEC filing on November 10, 2016.
Czirr's colleagues
We found three more compensation records of executives who worked with James C. Czirr at Galectin Therapeutics in 2013.